Local Anesthesia Drugs Market Research, 2031
The global local anesthesia drugs market size was valued at $2.6 billion in 2021, and is projected to reach $4.7 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031. Local anesthesia drugs are widely used to numb specific parts of the body so that the doctor can stitch up a wound or can perform operation or biopsy without the patient feeling any pain.Local anesthesia drugs differ from general anesthesia because general anesthesia drugs put the patient to sleep during the surgery or operation.
However, with local anesthesia the patient will be conscious during the procedure. Also, local anesthesia drugs are used to provide relief from pain caused by cancer or joint diseases. These factors are anticipated to propel the local anesthesia drugs market size during the forecast period.
The crucial role played by local anesthesia drugs in offering pain relief is anticipated to boost the market growth. The local anesthesia drugs relieve pain by blocking the nerves from carrying pain signal to the brain. This blockage saves the patients from feeling pain. Although this blockage is temporary and nerves will start working normally after some period of time. Local anesthesia is a simpler process as only the body is numbed while the patient is still awake. These factors are anticipated to boost the local anesthesia drugs market growth during the forecast period.
Some of the side effects associated with local anesthesia drugs include vomiting and nausea. Also, the presence of general anesthesia as a substitute for local anesthesia is estimated to restrict the local anesthesia market demand in the coming years. General anesthesia is used for extensive and long procedures where after injecting anesthesia patients fall asleep and by the time the patient wakes up the surgery is done.
Local anesthesia drugs offer several advantages to the patient as well as doctors. For instance, local anesthesia relieves pain while the patient is alert & conscious as only body is numb. Also, anesthesiologist is not required for injecting local anesthesia drugs. The surgeons or doctors can provide local anesthesia drugs before starting operation of procedure. The side-effects associated with local anesthesia drugs are very mild and uncommon. Owing to these factors, the risk of aspiration pneumonia is less, there is no delay in the procedure, and patients can go home sooner. Additionally, the cost of local anesthesia drugs namely procaine, chloroprocaine, and tetracaine is relatively less. These factors are anticipated to have positive impact on local anesthesia drugs industry during the projection timeframe.
The key players profiled in this report include Novartis AG, Aspen Pharmacare, Sagent Pharmaceuticals, Pacira Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi, Mylan N.V., GSK plc., AstraZeneca plc, and Hikma Pharmaceuticals plc.
The local anesthesia drugs market is segmented on the basis of drugs type, application, and region. As per drugs type, the market is divided into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and other local anesthetics. By application, the market is classified into injectable and surface anesthetic. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The local anesthesia drugs market is segmented into Drugs Type and Application.
By drugs type, the Lidocaine segment dominated the market in 2021. Lidocaine is widely used local anesthesia drug that is used to produce numbness on skin before surgical injections or procedures. Lidocaine topical cream is used for inducing loss of feeling or numbness before specific medical procedures. Lidocaine is applied on skin or genital area to cause numbness or loss of feeling. It effectively works by blocking the transmission of nerve signals in the body that reduces the pain sensation. It is widely used to prevent pain caused by injections, minor surgeries, or drawing of blood from vein. These factors are anticipated to boost the Lidocaine segment growth during the forecast period.
By application, the injectable segment dominated the global local anesthesia drugs market share in 2021. The injectable local anesthesia drugs are quite common and they have been in use since long time. Also, the injectable anesthetics are cost effective that will be used for numbness during the medical procedures. The injectable local anesthesia drugs act as roadblock between source of pain and brain that temporarily inhibits the activity of nerves to transmit the signals to brain thereby creating a feeling of numbness in patients. These aspects are anticipated to boost the popularity of injectable local anesthesia drugs market in the analysis timeframe.
By region, North America dominated the global market in 2021 and is anticipated to grow at a significant rate during the forecast period. This growth is majorly attributed to increase in the number of surgical procedures performed in this region. Also, improved access to healthcare facilities, rapid advancements in the healthcare sector, and high per capita income are the major growth driving factors. Additionally, rising cases of surgeries and chronic diseases are anticipated to boost the North America local anesthesia drugs market opportunity. For instance, the cases of skin or breast biopsy, surgical procedures involved in repairing broken bone, or stitching cuts is anticipated to propel the market demand in the coming years.
Impact of COVID-19 on the Global Local Anesthesia Drugs Industry
The COVID-19 pandemic has negatively impacted several businesses around the globe owing to social distancing norms and the closure of several businesses due to economic crisis
However, the pandemic impact on the local anesthesia drugs market was moderate and the demand for local anesthesia drugs have shown moderate increase. This is majorly owing to increase in hospitalization rate owing to rise in the admission of patients to the hospitals for surgeries and health complications
As the local anesthesia drugs are widely used in minor surgical procedures its demand during the pandemic has increased to some extent. However, only patients with severe health complications were admitted to the hospitals. Hospitals were committed to work closely with the healthcare providers and government during this crucial time to provide timely treatment to the patients who are in the need for same
For instance, the cardiac care and bone & joint surgeries that involve several diagnostic tests and procedures have led to an increase in demand for local anesthesia drugs during the COVID-19 pandemic. Many hospitals have also stocked their inventory of essential medicines to avoid any delay in the treatment. At the same time, several non-emergency surgical procedures were delayed as hospitals were overwhelmed with COVID-19 patients
The growing need to address the increasing demand for essential healthcare services, to enhance the capacity of healthcare systems, and to eliminate the backlog of care have led to moderate impact on the local anesthesia drugs market growth. Owing to all the above-mentioned factors, the local anesthesia drugs market demand moderately increased during the pandemic
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the local anesthesia drugs market analysis from 2021 to 2031 to identify the prevailing local anesthesia drugs market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the local anesthesia drugs market segmentation assists to determine the prevailing local anesthesia drugs market forecast.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global local anesthesia drugs market trends, key players, market segments, application areas, and market growth strategies.
Local Anesthesia Drugs Market Report Highlights
| Aspects | Details |
 Market Size By 2031 | USD 4.7 billion |
 Growth Rate | CAGR of 6.4% |
 Forecast period | 2021 - 2031 |
 Report Pages | 260 |
 By Drugs Type |
|
 By Application |
|
 By Region |
|
 Key Market Players | Fresenius Kabi AG, Sagent Pharmaceuticals, Pfizer Inc., Mylan N.V., Pacira Pharmaceuticals, Inc., Novartis AG, Septodont Healthcare India Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Aspen Holdings, Baxter International Inc. |
Analyst Review
The demand for local anesthesia drugs is rising across the world as they play a major role in pain management during minor surgical procedures. Some of the commonly used local anesthesia drugs are procaine, chloropropane, ropivacaine, tetracaine, lidocaine, bupivacaine, and mepivacaine. Local anesthesia drugs can be used in the form of local anesthetic ointment, nerve blocks, and local injection. The topical anesthesia drugs are available in the form of creams, liquids, gels, sprays, and patches. Local anesthesia drugs find a range of applications in surgical processes namely cataract surgery, catheter insertion, IV insertion, removing stitches, laser treatments, and endoscopy. In addition, over the counter topical anesthesia drugs can help in managing sore throat, minor burns, bug bites, open wounds, and hemorrhoids. The injectable local anesthesia drugs are used for dental treatments namely root canal, pacemaker insertion, deep wart removal, and diagnostic tests such as lumbar puncture or bone marrow biopsy. These factors are anticipated to boost the local anesthesia drugs market growth in the upcoming years. However, some of the side effects of local anesthesia drugs include twitching, numbness, dizziness, ringing in the ears, and others which are estimated to restrict the market growth. Local anesthesia drugs just numbs a small body part to prevent the pain. With local anesthesia the breathing muscles are not paralyzed and the patient can breathe without assistance.
Among the analyzed regions, North America is expected to account for the highest revenue share in the market in 2021, followed by Europe, Asia-Pacific, and LAMEA. This is majorly attributed to the better access to healthcare facilities and growing incidences of surgeries and medical procedures such as cataract surgeries, laser treatments, pacemaker insertion, and others.
The use of local anesthesia drugs in reducing pain during different medical procedures such as IV insertion, removing or applying stitches, endoscopy, laser treatments, catheter insertion, and others are the major drivers that will generate excellent opportunities in the market in the upcoming years.
The major growth strategies adopted by local anesthesia drugs market players include partnership, acquisition, and business expansion.
The injectable sub-segment of the application segment acquired the maximum share of the global local anesthesia drugs market in 2021.
The report provides an extensive qualitative and quantitative analysis of the current trends and future estimations of the global local anesthesia drugs market from 2022 to 2031 to determine the prevailing opportunities.
The growing application of local anesthesia drugs in deep wart removal and dental procedures such as root canal as well as skin biopsy, pacemaker insertion, and diagnostic tests is estimated to drive the market adoption.
Asia-Pacific will provide more business opportunities for the global local anesthesia drugs market in the future.
Novartis AG, Aspen Pharmacare, and Sagent Pharmaceuticals are the major players in the local anesthesia drugs market.
Loading Table Of Content...
